ZA8408495B - Production of polypeptides in insect cells - Google Patents

Production of polypeptides in insect cells

Info

Publication number
ZA8408495B
ZA8408495B ZA848495A ZA8408495A ZA8408495B ZA 8408495 B ZA8408495 B ZA 8408495B ZA 848495 A ZA848495 A ZA 848495A ZA 8408495 A ZA8408495 A ZA 8408495A ZA 8408495 B ZA8408495 B ZA 8408495B
Authority
ZA
South Africa
Prior art keywords
polypeptides
production
insect cells
insect
cells
Prior art date
Application number
ZA848495A
Inventor
Lois K Miller
Original Assignee
Idaho Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US57545384A priority Critical
Application filed by Idaho Res Found filed Critical Idaho Res Found
Publication of ZA8408495B publication Critical patent/ZA8408495B/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24300383&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA8408495(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
ZA848495A 1984-01-31 1984-10-31 Production of polypeptides in insect cells ZA8408495B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US57545384A true 1984-01-31 1984-01-31

Publications (1)

Publication Number Publication Date
ZA8408495B true ZA8408495B (en) 1985-09-25

Family

ID=24300383

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA848495A ZA8408495B (en) 1984-01-31 1984-10-31 Production of polypeptides in insect cells

Country Status (8)

Country Link
EP (1) EP0155476A1 (en)
JP (1) JPS615787A (en)
AU (1) AU3824285A (en)
DK (1) DK518384A (en)
ES (1) ES8604308A1 (en)
GR (1) GR850265B (en)
IL (1) IL73942D0 (en)
ZA (1) ZA8408495B (en)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879236A (en) * 1984-05-16 1989-11-07 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
JPH0573389B2 (en) * 1984-06-21 1993-10-14 Daiichi Seiyaku Co
IL80529D0 (en) * 1985-11-14 1987-02-27 Daiichi Seiyaku Co Method of producing peptides
EP0228036A3 (en) * 1985-12-18 1988-09-07 Microgenesys, Inc. Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
GR871029B (en) 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
EP0260090A3 (en) * 1986-09-08 1988-07-27 David H.L. Bishop Expression of hepatitis b viral antigens from recombinant baculovirus vectors
US5071748A (en) * 1986-09-09 1991-12-10 Genetics Institute, Inc. Mixed baculovirus compositions and uses thereof
ZA8706696B (en) * 1986-09-09 1988-05-25 Genetics Inst Method for producing a heterologous protein in insect cells
US5041379A (en) * 1987-03-16 1991-08-20 American Biogenetic Science, Inc. Heliothis expression systems
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
GB8810808D0 (en) * 1988-05-06 1988-06-08 Wellcome Found Vectors
JP2511494B2 (en) * 1988-05-12 1996-06-26 日本ゼオン株式会社 The process of Japanese encephalitis virus surface antigen protein
JPH0221955A (en) * 1988-07-07 1990-01-24 Kyoritsu Gokin Seisakusho:Kk Fluid injection nozzle
SE8802939D0 (en) * 1988-08-19 1988-08-19 Kabigen Ab A method for the production and isolation of a fusion protein in eukaryotic cells
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
AU4647889A (en) * 1988-11-18 1990-06-12 Cetus Corporation Insect signal peptide mediated secretion of recombinant proteins
US5244805A (en) * 1989-05-17 1993-09-14 University Of Georgia Research Foundation, Inc. Baculovirus expression vectors
DE69233022T2 (en) 1991-11-04 2004-02-12 Genetics Institute, LLC, Cambridge Recombinant bone morphogenetic protein heterodimer, compositions and methods for use
PT1378572E (en) 1993-05-12 2007-01-31 Genetics Inst Bmp-11 compositions
US6027919A (en) 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
AU1377395A (en) * 1993-12-23 1995-07-10 University Technologies International Inc. Methods of expressing proteins in insect cells and methods of killing insects
US5629167A (en) 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
US6165748A (en) 1997-07-11 2000-12-26 Genetics Institute, Inc. Frazzled nucleotide sequences and expression products
DK1007546T3 (en) 1997-08-27 2009-03-16 Novartis Vaccines & Diagnostic Molecular mimetics of meningococcal B epitopes
AU9363798A (en) 1997-11-06 1999-05-31 Chiron S.P.A. Neisserial antigens
ES2333071T5 (en) 1998-01-14 2015-08-17 Novartis Vaccines And Diagnostics S.R.L. Neisseria meningitidis antigens
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
EP1645631B1 (en) 1998-05-01 2007-10-24 Novartis Vaccines and Diagnostics, Inc. Neisseria antigens and compositions
AT386804T (en) 1998-10-15 2008-03-15 Novartis Vaccines & Diagnostic Genes with changed expression in metastic breast or thick-darm cancer cells
EP2308974A3 (en) 1999-10-14 2011-08-10 Clontech Laboratories Inc. Anthozoa derived chromo/fluoroproteins and methods for using the same
JP2003524389A (en) 1998-12-16 2003-08-19 カイロン コーポレイション Human cyclin-dependent kinase (hPNQALRE)
EP1228217B1 (en) 1999-04-30 2012-11-21 Novartis Vaccines and Diagnostics S.r.l. Conserved neisserial antigens
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
PT2275552E (en) 1999-10-29 2015-12-07 Glaxosmithkline Biolog Sa Neisserial antigenic peptides
ES2386317T3 (en) 2000-01-10 2012-08-17 Novartis Vaccines And Diagnostics, Inc. differentially expressed genes in breast cancer
BR0107679A (en) 2000-01-17 2004-07-06 Chiron Spa outer membrane vesicle vaccine (OMV) comprising outer membrane proteins from serogroup B Neisseria meningitidis
US6689599B1 (en) 2000-10-20 2004-02-10 Genetics Institute, Llc Aggrecanase molecules
SG165981A1 (en) 2000-10-27 2010-11-29 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
AU2002305151A1 (en) 2001-04-06 2002-10-21 Georgetown University Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002258728A1 (en) 2001-04-06 2002-10-21 Georgetown University Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) 2001-04-06 2002-10-21 Georgetown University Gene brcc2 and diagnostic and therapeutic uses thereof
WO2003012038A2 (en) 2001-07-27 2003-02-13 Wyeth Aggrecanase molecules
EP2168596B1 (en) 2001-12-12 2012-05-23 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia trachomatis
AT439368T (en) 2001-12-19 2009-08-15 Univ Chicago Fast-treating fluorescent proteins and method for their use
CA2474908A1 (en) 2002-01-31 2003-08-07 Wyeth Aggrecanase molecules
AU2003215070A1 (en) 2002-02-05 2003-09-02 Wyeth Truncated aggrecanase molecules
US7244565B2 (en) 2002-04-10 2007-07-17 Georgetown University Gene shinc-3 and diagnostic and therapeutic uses thereof
US7138512B2 (en) 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
EP1572720A4 (en) 2002-05-24 2008-12-24 Nps Allelix Corp Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
AU2003239865A1 (en) 2002-05-24 2003-12-12 Restoragen Inc. Method for universal enzymatic production of bioactive peptides
AT466875T (en) 2002-11-15 2010-05-15 Novartis Vaccines & Diagnostic Unexpected surface proteins in neisseria meningitidis
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
DK1675608T3 (en) 2003-09-12 2007-07-09 Wyeth Corp Injectable solid calcium phosphate rods for administration of osteogenic proteins
AT541932T (en) 2003-11-21 2012-02-15 Nps Pharma Inc Preparation of glucagonic peptide 2 and analog
NZ548255A (en) 2004-02-02 2010-10-29 Ambrx Inc Modified human interferon polypeptides and their uses
KR101222281B1 (en) 2004-03-29 2013-01-28 가르파마 컴퍼니 리미티드 Novel galectin 9 modification protein and use thereof
US7250298B2 (en) 2004-04-07 2007-07-31 The University Of Chicago Monomeric red fluorescent proteins
CA2568952C (en) 2004-06-18 2019-05-21 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
AT542920T (en) 2004-12-22 2012-02-15 Ambrx Inc Modified human growth hormone
SG158149A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
CA2602175C (en) 2005-03-21 2012-11-27 Applera Corporation Alpha ketoamide compounds as cysteine protease inhibitors
US20070054360A1 (en) 2005-05-12 2007-03-08 Zeren Gao Compositions and methods for modulating immune responses
US7749704B2 (en) 2005-11-01 2010-07-06 Mayo Foundation For Medical Education And Research Promoter polymorphisms of the BLyS gene and use in diagnostic methods
KR20080079643A (en) 2005-11-16 2008-09-01 암브룩스, 인코포레이티드 Methods and compositions comprising non-natural amino acids
EP2035035A2 (en) 2006-06-09 2009-03-18 Novartis AG Immunogenic compositions for streptococcus agalactiae
DK2615108T3 (en) 2006-09-08 2017-01-30 Ambrx Inc Modified human plasma polypeptide or fc scaffolds and their applications
US7985783B2 (en) 2006-09-21 2011-07-26 The Regents Of The University Of California Aldehyde tags, uses thereof in site-specific protein modification
CA2682147C (en) 2007-03-30 2017-08-08 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
CA2971794A1 (en) 2007-10-04 2009-04-09 Zymogenetics, Inc. B7 family member zb7h6 and related compositions and methods
US8679749B2 (en) 2007-11-01 2014-03-25 The University Of Chicago Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
MX338336B (en) 2007-11-20 2016-04-07 Ambrx Inc Modified insulin polypeptides and their uses.
WO2009073511A2 (en) 2007-11-30 2009-06-11 Mayo Foundation For Medical Education And Research Polymorphisms of the blys gene and use in diagnostic methods
CN103694337B (en) 2008-02-08 2016-03-02 Ambrx公司 Modified leptin polypeptides and uses thereof
AU2009274076C1 (en) 2008-07-23 2014-04-17 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
JP5709754B2 (en) 2008-09-26 2015-04-30 アンブルックス,インコーポレイテッドAmbrx,Inc. Microorganisms and vaccines that rely on replication with unnatural amino acids
BRPI0919403A2 (en) 2008-09-26 2017-09-26 Ambrx Inc modified animal erythropoietin polypeptides and their uses
EP2292781A1 (en) 2009-08-17 2011-03-09 Genethon Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
EP2333074A1 (en) 2009-12-14 2011-06-15 Robert Steinfeld Substances and methods for the treatment of lysosmal storage diseases
CA2784800A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
MX349301B (en) 2009-12-21 2017-07-21 Ambrx Inc Modified bovine somatotropin polypeptides and their uses.
BR112013003522A8 (en) 2010-08-17 2017-12-26 Ambrx Inc "modified relaxin polypeptides comprising a non-naturally encoded amino acid, use, method of preparation as well as nucleic acid encoding them"
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
BR112014001863A2 (en) 2011-07-27 2017-02-21 Genethon enhanced baculovirus expression systems
BR112016005576A2 (en) 2013-09-12 2017-09-12 Biomarin Pharm Inc adeno-associated virus factor viii vectors
CN110078814A (en) 2014-10-24 2019-08-02 百时美施贵宝公司 FGF-21 polypeptide of modification and application thereof
KR20190032375A (en) 2016-07-26 2019-03-27 바이오마린 파머수티컬 인크. The novel adeno-associated virus capsid protein
KR20190115049A (en) 2017-02-08 2019-10-10 브리스톨-마이어스 스큅 컴퍼니 Modified relaxin polypeptides comprising pharmacokinetic enhancers and uses thereof
WO2019217513A2 (en) 2018-05-09 2019-11-14 Biomarin Pharmaceutical Inc. Methods of treating phenylketonuria

Also Published As

Publication number Publication date
DK518384D0 (en) 1984-10-31
JPS615787A (en) 1986-01-11
GR850265B (en) 1985-05-27
IL73942D0 (en) 1985-03-31
ES8604308A1 (en) 1986-01-16
DK518384A (en) 1985-07-01
ES537766D0 (en)
ES537766A0 (en) 1986-01-16
AU3824285A (en) 1985-08-08
EP0155476A1 (en) 1985-09-25

Similar Documents

Publication Publication Date Title
US4714680B1 (en) Human stem cells
DE3572982D1 (en) Chemically modified lymphokine and production thereof
GB2182194B (en) Electrochemical cell
DE3276241D1 (en) Expression of polypeptides in yeast
DE3568015D1 (en) Laminate structure and production of the same
GB2157478B (en) Fuel cell
GB2163595B (en) Improvements in fuel cell structures
DE3561636D1 (en) Formation of features in optical material
GB2159489B (en) Silage production
IL63412D0 (en) Array of photovoltaic cells and its production
EP0165059A3 (en) Low-surface energy material
GB8525155D0 (en) Composite porous material
EP0289183A3 (en) Production of rapeseed protein materials
DE3565343D1 (en) Electrochemical cell arrangements
GB8702278D0 (en) Formed material
JPS6190667A (en) Nonwoven material and its production
JPS60235778A (en) Ceramic structure and manufacture
JPS63110201A (en) Novel citosan derivative and its production
IL67853A (en) Solar cell and its production
JPS61116868A (en) Memory cell array and manufacture thereof
JPS61280654A (en) Vertical dram cell and making thereof
IL71691A (en) Production of interferon-ypsilon
JPS61101533A (en) Biologically decomposable polypeptide and its production
JPS61179731A (en) Three-dimensional structure material
EP0198015A4 (en) Production of streptavidin-like polypeptides.